Charles Campbell Roberts Chief Investment Strategist Ark Investment Management
Charles Campbell Roberts is a visionary investor and entrepreneur focused on leveraging disruptive technologies to create a healthier, happier, and more balanced society. Currently serving as Chief Investment Strategist at ARK Investment Management, he leads private investments in transformative technologies, with a focus on artificial intelligence and multiomics. With $360 million under management across two funds, he drives innovation and market growth through venture and crossover strategies.
As co-founder of Freenome, he spearheads advancements in early cancer detection by integrating machine learning with computational biology. His work extends to Relation Therapeutics, where he applies machine learning to target discovery and combination drug repurposing. He also advises groundbreaking initiatives such as NewLimit, focused on epigenetic reprogramming, and has held leadership roles in numerous ventures, including Yourgene Health and Centauri Therapeutics.
An alumnus of Oxford University, University College London, and the University of Dundee, Charles blends medical expertise with entrepreneurial acumen. His career spans roles as a clinician, surgeon, and thought leader in health technology, making him a pivotal figure in advancing technologies that impact global health and well-being.
Cornell Financial Engineering Manhattan 2025 Future of Finance & Ai Conference
